Gene · 7030
Papers3,398
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
381 to 400 of 3,398
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Dimorphic effect of TFE3 in determining mitochondrial and lysosomal content in muscle following denervation. | Skelet Muscle | 2024 | 38643162 | PubTator, text mining | PubMed |
| An unusual case of primary splenic soft part alveolar sarcoma: case report and review of the literature with emphasis on the spectrum of TFE3-associated neoplasms. | Diagn Pathol | 2024 | 38643139 | PubTator, text mining | PubMed |
| Autophagy gene expression in skeletal muscle of older individuals is associated with physical performance, muscle volume and mitochondrial function in the study of muscle, mobility and aging (SOMMA). | Aging Cell | 2024 | 38627910 | PubTator, text mining | PubMed |
| A case of pancreatic PEComa with prominent inflammatory cell infiltration: the inflammatory subtype is a distinct histologic group of PEComa. | Diagn Pathol | 2024 | 38622713 | PubTator, text mining | PubMed |
| Papillary Renal Cell Carcinoma in Transplanted Kidney and Xp11.2 Translocation/Transcription Factor E3-Rearranged Renal Cell Carcinoma in the Native Kidney: A Case Report. | J Korean Soc Radiol | 2024 | 38617860 | PubTator, text mining | PubMed |
| d-mannose targets PD-1 to lysosomal degradation and enhances T cell-mediated anti-tumor immunity. | Cancer Lett | 2024 | 38615929 | PubTator, text mining | PubMed |
| Multiple and hereditary renal tumors: a review for radiologists. | Radiologia (Engl Ed) | 2024 | 38614530 | PubTator, text mining | PubMed |
| TFE3-SLC36A1 axis promotes resistance to glucose starvation in kidney cancer cells. | J Biol Chem | 2024 | 38599381 | PubTator, text mining | PubMed |
| TFE3 -Rearranged PEComa/PEComa-like Neoplasms : Report of 25 New Cases Expanding the Clinicopathologic Spectrum and Highlighting its Association With Prior Exposure to Chemotherapy. | Am J Surg Pathol | 2024 | 38597260 | PubTator, text mining | PubMed |
| Treatment of metastatic TFE3 microphthalmia transcription factor translocation renal cell carcinoma: a case report. | Transl Pediatr | 2024 | 38590368 | PubTator, text mining | PubMed |
| TFE3/PI3K/Akt/mTOR Axis in Renal Cell Carcinoma Affects Tumor Microenvironment. | Am J Pathol | 2024 | 38588851 | PubTator, text mining | PubMed |
| Integrated stress response plasticity governs normal cell adaptation to chronic stress via the PP2A-TFE3-ATF4 pathway. | Res Sq | 2024 | 38585734 | PubTator, text mining | PubMed |
| Cutaneous Syncytial Myoepithelioma: An Uncommon and Distinct Variant of Cutaneous Epithelioid Neoplasm. | Am J Dermatopathol | 2024 | 38574041 | PubTator, text mining | PubMed |
| Epithelioid hemangioendothelioma-its history, clinical features, molecular biology and current therapy. | Jpn J Clin Oncol | 2024 | 38555494 | PubTator, text mining | PubMed |
| Perivascular Epithelioid Cell-Family Tumors in Children, Adolescents, and Young Adults: Clinicopathologic Features in 70 Cases. | Arch Pathol Lab Med | 2024 | 38547914 | PubTator, text mining | PubMed |
| TFE3-RCC of the right kidney in an eight-year-old child. | Asian J Surg | 2024 | 38521744 | PubTator, text mining | PubMed |
| The New WHO Category of "Molecularly Defined Renal Carcinomas": Clinical and Diagnostic Features and Management Implications. | Urol Oncol | 2024 | 38519377 | PubTator, text mining | PubMed |
| Establishment and characterization of NCC-ASPS2-C1: a novel patient-derived cell line of alveolar soft part sarcoma. | Hum Cell | 2024 | 38478355 | PubTator, text mining | PubMed |
| A nomogram based on TFE3 IHC results and clinical factors as a preliminary screening scheme for TFE3-rearranged renal cell carcinoma. | Cancer Med | 2024 | 38477529 | PubTator, text mining | PubMed |
| Hepatic and perihepatic PEComas: A study describing a series of five rare cases. | Indian J Pathol Microbiol | 2024 | 38427771 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7030/papers?page=20